Summary:
AMR Clinical Norfolk is
conducting a clinical research study evaluating an investigational mRNA
COVID-19 vaccine for healthy adults ages 50 to 64.
Qualified Participants Must:
Are healthy adults between 50 and 64 years of age.
Have not tested positive for COVID and have not received a COVID vaccine in the past three months.
Meet other study criteria.
Qualified Participants May Receive:
All study-related care and the investigational
vaccine or placebo are provided at no cost, and reimbursement up to $650.00 may
be available for study-related time and travel.